Dr. Priyom Bose

Dr. Priyom Bose

Feature Writer

B.Sc. Botany, M.Sc. Plant Biology and Biotechnology, Ph.D. Plant Biology and Biotechnology

Priyom holds a Ph.D. in Plant Biology and Biotechnology from the University of Madras, India. She is an active researcher and an experienced science writer. Priyom has also co-authored several original research articles that have been published in reputed peer-reviewed journals. She is also an avid reader and an amateur photographer.

Articles from Priyom

Recent innovations in infectious disease diagnostics

Recent innovations in infectious disease diagnostics

17 Oct 2022
In silico studies identify potent plant metabolites capable of inhibiting SARS-CoV-2

In silico studies identify potent plant metabolites capable of inhibiting SARS-CoV-2

16 Oct 2022
Chinese study determines the real-world effectiveness of COVID-19 vaccines

Chinese study determines the real-world effectiveness of COVID-19 vaccines

14 Oct 2022
The impact of humidity levels on viral transmission and viability

The impact of humidity levels on viral transmission and viability

13 Oct 2022
The health status and exercise capacity of COVID-19 survivors one year after hospital discharge

The health status and exercise capacity of COVID-19 survivors one year after hospital discharge

13 Oct 2022
Molnupiravir and nirmatrelvir-ritonavir treatments are effective in reducing mortality among high-risk COVID-19 patients

Molnupiravir and nirmatrelvir-ritonavir treatments are effective in reducing mortality among high-risk COVID-19 patients

12 Oct 2022
Immune-mediated inflammatory diseases following COVID-19

Immune-mediated inflammatory diseases following COVID-19

12 Oct 2022
Modeling the risk factors for household transmission of SARS-CoV-2

Modeling the risk factors for household transmission of SARS-CoV-2

12 Oct 2022
Pulmonary radiological patterns in patients diagnosed with SARS-CoV-2 pneumonia

Pulmonary radiological patterns in patients diagnosed with SARS-CoV-2 pneumonia

11 Oct 2022
BNT162b2 COVID-19 booster vaccine induces robust humoral responses independent of the interval between the first two doses

BNT162b2 COVID-19 booster vaccine induces robust humoral responses independent of the interval between the first two doses

11 Oct 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback